Atrial fibrillation (AF) and atrial flutter (AFL) are common arrhythmias in elderly patients, which frequently coexist and complicate the course of treatment for each other in old people. Besides, the management of geriatric AF/AFL or HF has been a challenge for physicians. In some situations, atrial rhythms may not be well controlled by anti-arrhythmic drugs, making cardioversion to sinus rhythm. The side-effect of anticoagulation therapy on these diseases is worth attention. It has many disadvantages to traditional ablation strategy and catheter. More recent techniques like left atrial appendage (LAA) have been developed and becoming highly attractive for the management of AF/AFL in the future. Novel drugs targeting specific ion channels are approaching the stages of clinical investigation. Although previous research and clinical therapeutics have made profound progress on geriatric AF/AFL or HF, the evidence related to its mechanisms and treatments remains unclear and needs to be further investigated.
This research topic aims to look for studies on current advancements in mechanisms and treatment options for geriatric atrial fibrillation/atrial flutter or heart failure.
We wish to encourage submissions of Original Research, Reviews, Systematic Reviews, and Meta-analyses, Case Reports to broaden our knowledge and open new research directions. Subtopics of interests include, but are not limited to:
• Cellular and pathophysiological mechanism and bioinformatic analyses for mechanism exploration of geriatric AF/AFL or HF.
• Optimal rate/rhythm control strategy of geriatric AF/AFL or HF.
• Newly progress in comparison of treatment effects of geriatric AF/AFL or HF in different areas or hospitals.
• New technologies of catheter ablation, and new mapping in treating geriatric AF/AFL or HF.
• New advances in anticoagulation for geriatric AF/AFL or HF in the old patients.
• Left atrial appendage occlusion (LAA) as stroke prevention in geriatric AF/AFL or HF
Atrial fibrillation (AF) and atrial flutter (AFL) are common arrhythmias in elderly patients, which frequently coexist and complicate the course of treatment for each other in old people. Besides, the management of geriatric AF/AFL or HF has been a challenge for physicians. In some situations, atrial rhythms may not be well controlled by anti-arrhythmic drugs, making cardioversion to sinus rhythm. The side-effect of anticoagulation therapy on these diseases is worth attention. It has many disadvantages to traditional ablation strategy and catheter. More recent techniques like left atrial appendage (LAA) have been developed and becoming highly attractive for the management of AF/AFL in the future. Novel drugs targeting specific ion channels are approaching the stages of clinical investigation. Although previous research and clinical therapeutics have made profound progress on geriatric AF/AFL or HF, the evidence related to its mechanisms and treatments remains unclear and needs to be further investigated.
This research topic aims to look for studies on current advancements in mechanisms and treatment options for geriatric atrial fibrillation/atrial flutter or heart failure.
We wish to encourage submissions of Original Research, Reviews, Systematic Reviews, and Meta-analyses, Case Reports to broaden our knowledge and open new research directions. Subtopics of interests include, but are not limited to:
• Cellular and pathophysiological mechanism and bioinformatic analyses for mechanism exploration of geriatric AF/AFL or HF.
• Optimal rate/rhythm control strategy of geriatric AF/AFL or HF.
• Newly progress in comparison of treatment effects of geriatric AF/AFL or HF in different areas or hospitals.
• New technologies of catheter ablation, and new mapping in treating geriatric AF/AFL or HF.
• New advances in anticoagulation for geriatric AF/AFL or HF in the old patients.
• Left atrial appendage occlusion (LAA) as stroke prevention in geriatric AF/AFL or HF
